Table 5.
Summary of lifetime prevalence estimates
| Strata | N | Min | IQ25 | Median | IQ75 | Max |
|---|---|---|---|---|---|---|
| Overall | 30 | 0.06 % | 0.34 % | 0.48 % | 0.85 % | 5.00 % |
| Design | ||||||
| Cross-sectional | 18 | 0.06 % | 0.28 % | 0.44 % | 0.85 % | 5.00 % |
| Cohort | 12 | 0.21 % | 0.35 % | 0.56 % | 0.87 % | 1.54 % |
| Region | ||||||
| Africa | 5 | 0.06 % | 0.40 % | 0.47 % | 0.80 % | 5.00 % |
| North America | 3 | 0.15 % | 0.20 % | 0.25 % | 0.86 % | 1.46 % |
| Asia | 6 | 0.10 % | 0.16 % | 0.33 % | 0.49 % | 0.88 % |
| Europe | 13 | 0.21 % | 0.39 % | 0.52 % | 0.87 % | 1.54 % |
| Oceania | 2 | 0.40 % | 0.49 % | 0.58 % | 0.66 % | 0.75 % |
| Sample Size | ||||||
| <5000 | 5 | 0.35 % | 0.49 % | 0.60 % | 0.75 % | 5.00 % |
| 5000–9999 | 8 | 0.10 % | 0.15 % | 0.40 % | 0.61 % | 1.30 % |
| 10,000–49,999 | 7 | 0.06 % | 0.40 % | 0.61 % | 0.84 % | 1.54 % |
| 50,000–99,999 | 3 | 0.24 % | 0.36 % | 0.47 % | 0.50 % | 0.52 % |
| 100,000+ | 7 | 0.21 % | 0.29 % | 0.41 % | 1.16 % | 1.46 % |
| Publication Date | ||||||
| 1990–2002 | 16 | 0.06 % | 0.24 % | 0.40 % | 0.66 % | 5.00 % |
| 2003–2013 | 14 | 0.10 % | 0.40 % | 0.51 % | 0.88 % | 1.54 % |
| Assessment Yeara | ||||||
| <1990 | 10 | 0.06 % | 0.26 % | 0.44 % | 0.61 % | 1.30 % |
| 1990–1999 | 11 | 0.15 % | 0.32 % | 0.40 % | 0.61 % | 5.00 % |
| 2000–2009 | 8 | 0.10 % | 0.49 % | 0.70 % | 0.94 % | 1.46 % |
| Quality Score | ||||||
| 0–7 | 7 | 0.13 % | 0.23 % | 0.75 % | 1.00 % | 1.30 % |
| 8–10 | 10 | 0.06 % | 0.35 % | 0.45 % | 0.59 % | 1.54 % |
| 11–15 | 13 | 0.10 % | 0.39 % | 0.47 % | 0.80 % | 5.00 % |
One study (Nuevo et al.) reported on multiple regions, and has been excluded from the “Region” analyses
aSelected estimates are the most recent year available. When assessment spanned multiple years, the median year was considered. 4 estimates did not have assessment years reported